# Meiji Pharmaceutical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/meiji-pharmaceutical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 72.3 |
| Citations | 187,070 |
| City | Tokyo |
| Country | JP |
| Description | Meiji Pharmaceutical University is a research organisation in Tokyo, JP. OpenAlex records 3,586 works and 187,070 citations for it. 1,070 researchers list it as their most recent affiliation. |
| Homepage | https://www.my-pharm.ac.jp |
| OpenAlex ID | https://openalex.org/I23172683 |
| Researchers | 1,070 |
| ROR ID | https://ror.org/00wm7p047 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q6810038 |
| Works | 3,586 |

## University papers

Showing 12 of 13.

- [Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion](https://scholariq.org/papers/binding-of-ovarian-cancer-antigen-ca125-muc16-to-mesothelin-mediates-cell/)
- [Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans](https://scholariq.org/papers/different-contributions-of-polymorphisms-in-vkorc1-and-cyp2c9-to-intra-and-inter/)
- [Pharmacogenetics of Warfarin Elimination and its Clinical Implications](https://scholariq.org/papers/pharmacogenetics-of-warfarin-elimination-and-its-clinical-implications/)
- [The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations](https://scholariq.org/papers/the-first-in-class-potassium-competitive-acid-blocker-vonoprazan-fumarate/)
- [Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo](https://scholariq.org/papers/generation-of-a-p16-reporter-mouse-and-its-use-to-characterize-and-target/)
- [Population differences in S‐warfarin metabolism between <i>CYP2C9</i> genotype‐matched Caucasian and Japanese patients](https://scholariq.org/papers/population-differences-in-s-warfarin-metabolism-between-i-cyp2c9-i-genotype/)
- [Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem](https://scholariq.org/papers/clinical-pharmacokinetics-of-verapamil-nifedipine-and-diltiazem/)
- [Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*](https://scholariq.org/papers/metabolism-of-warfarin-enantiomers-in-japanese-patients-with-heart-disease/)
- [Drug-Drug Interaction Profiles of Proton Pump Inhibitors](https://scholariq.org/papers/drug-drug-interaction-profiles-of-proton-pump-inhibitors/)
- [Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes](https://scholariq.org/papers/comparisons-between-in-vitro-and-in-vivo-metabolism-of-s-warfarin-catalytic/)
- [The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans](https://scholariq.org/papers/the-effect-of-dextro-levo-and-racemic-verapamil-on-atrioventricular-conduction/)
- [Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS) May Have Elevated Serotonin Concentrations in Colonic Mucosa as Compared with Diarrhea-Predominant Patients and Subjects with Normal Bowel Habits](https://scholariq.org/papers/patients-with-constipation-predominant-irritable-bowel-syndrome-ibs-may-have/)

## University researchers

- [Hirotoshi Echizen](https://scholariq.org/researchers/hirotoshi-echizen/)

## University top topics

Showing 8 of 25.

- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Synthesis and Biological Activity](https://scholariq.org/topics/synthesis-and-biological-activity-2/)
- [Fungal Infections and Studies](https://scholariq.org/topics/fungal-infections-and-studies/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Nail Diseases and Treatments](https://scholariq.org/topics/nail-diseases-and-treatments/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Microbial Natural Products and Biosynthesis](https://scholariq.org/topics/microbial-natural-products-and-biosynthesis/)
- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.